Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAPK8IP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | THRAP3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | KIAA2022 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | RAD54L | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | CASP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | ARHGAP45 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |
mRNA | POLR2A | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | EZH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | CASC3 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | QRICH1 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |